A "Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) Correlated With Mitigated Risks of Early Mortality, Cardiovascular and Renal Risks in Type 1 Diabetes (T1D) Subjects: Perspectives on the Economic Impact"
Year: 2026
Type: article
Abstract: This article presents a comprehensive review of the application of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in type 1 diabetes (T1D), with essential focus on the cardiovascular and renal benefits. This is a timely contribution to the field, especially given the deficiency of long-term data associated with T1D and GLP-1RA application. The discourse of GLP-1RAs outside the confines of their conventional functionality in type 2 diabetes (T2D) management depicts critical demands for further research in this sphere. This work instigates an innovative strategy to explicate the cardiovascular and renal benefits of GLP-1RAs in T1D persons; and integratively articulates the potential of these therapeutic medicatjons to ameliorate major adverse cardiovascular events (MACE) and progression of kidney disease, with nascent perspective in T1D management. The interdisciplinary conglomeration of cardiology, endocrinology, and nephrology enact a conformed strategy to diabetes research and clinical practice. Also, ethical concepts correlated to off-label therapeutic agents prescriptions substantiate and provide a nuanced elucidation of type 1 diabetes patient care. The article exposes significant interdisciplinary aspects in the useof GLP-1RAs in T1D. The ethical instances of off-label drug use depict challenges, issues, opportunities and priorities concerning clinical decision-making, especially with regard to patient autonomy versus traditional care protocols. The evaluation of economic impacts in novel pharmaceutical modalities is opportune and relevant, and requires future work delving into the socio-economic implications on broadening the analytic scope of the healthcare system.
Source: Medico Research Chronicles
Author: Chukwuma Sr, Chrysanthus
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7216814987
